1. Home
  2. ZBIO
  3. ZBIO News

Latest ZENAS BIOPHARMA INC (ZBIO) News on February 23, 2025

ZBIO

Argus Research

3 days ago

Daily – Vickers Top Buyers & Sellers for 02/20/2025

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases
ZBIO

GlobeNewswire

18 days ago

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

ZBIO

MT Newswires

19 days ago

Wolfe Research Initiates Coverage on Zenas BioPharma With Outperform Rating, $19 Price Target

Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference
ZBIO

GlobeNewswire

a month ago

Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference

Zenas BioPharma initiated with a Buy at H.C. Wainwright
ZBIO

TipRanks

2 months ago

Zenas BioPharma initiated with a Buy at H.C. Wainwright

ZBIO

MT Newswires

2 months ago

HC Wainwright Initiates Zenas BioPharma at Buy With $30 Price Target

Zenas BioPharma price target lowered to $35 from $40 at Morgan Stanley
ZBIO

TipRanks

2 months ago

Zenas BioPharma price target lowered to $35 from $40 at Morgan Stanley

ZBIO

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 12/05/2024

ZBIO

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 11/21/2024

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
ZBIO

GlobeNewswire

3 months ago

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
ZBIO

GlobeNewswire

3 months ago

Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
ZBIO

GlobeNewswire

4 months ago

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

Opening Day: Another trio of biotech IPOs make Friday debut
ZBIO

TipRanks

4 months ago

Opening Day: Another trio of biotech IPOs make Friday debut

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
ZBIO

GlobeNewswire

5 months ago

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

Share on Social Networks: